The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells. (Q40122801)
Jump to navigation
Jump to search
scientific article published on 7 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells. |
scientific article published on 7 June 2007 |
Statements
The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells (English)
J Burthem
K Rees-Unwin
R Mottram
J Adams